Interestingly, we found that RAN acetylation was significantly decreased in CRC cells after RSL1D1 knockdown, while the acetylation levels of RAN were greatly increased in CRC cells overexpressing RSL1D1 (Fig. S4G). Here, RSL1D1 is linked to colorectal carcinoma.